ASRPS is a peptide of 60 amino acids encoded by LINC00908, which is down-regulated in triple-negative breast cancer (TNBC), and can inhibit angiogenesis and exert an anti-tumor effect in TNBC [26]. This evidence concerns the gene LINC00908 and neoplasm.